Loading...
ENDRA Life Sciences Inc.
NDRA•NASDAQ
Healthcare
Medical - Diagnostics & Research
$6.35
$-0.25(-3.79%)
ENDRA Life Sciences Inc. (NDRA) Financial Performance & Income Statement Overview
Review ENDRA Life Sciences Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
100.00%
↑ 100.00%
Net Income Growth
-14.39%
↓ 14.39%
Operating Cash Flow Growth
22.50%
↑ 22.50%
Operating Margin
-3798.02%
↓ 3798.02%
Gross Margin
26.31%
↑ 26.31%
Net Profit Margin
-4616.53%
↓ 4616.53%
ROE
-196.24%
↓ 196.24%
ROIC
-308.53%
↓ 308.53%
ENDRA Life Sciences Inc. (NDRA) Income Statement & Financial Overview
Review ENDRA Life Sciences Inc.'s (NDRA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $211600.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $105800.00 | $0.00 | $50124.00 | $55676.00 |
| Gross Profit | $105800.00 | $0.00 | -$50124.00 | -$55676.00 |
| Gross Profit Ratio | $0.50 | $0.00 | ||
| R&D Expenses | $637957.00 | $794444.00 | $716366.00 | $1.04M |
| SG&A Expenses | $3.66M | $714570.00 | $1.51M | $1.68M |
| Operating Expenses | $4.30M | $1.51M | $2.23M | $2.72M |
| Total Costs & Expenses | $4.46M | $1.51M | $2.23M | $2.78M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $46363.00 | $54009.00 | $50124.00 | $55676.00 |
| EBITDA | -$4.25M | -$1.50M | -$2.18M | -$2.72M |
| EBITDA Ratio | -$20.09 | |||
| Operating Income | -$4.30M | -$1.51M | -$2.23M | -$2.78M |
| Operating Income Ratio | -$20.31 | |||
| Other Income/Expenses (Net) | $147735.00 | -$845076.00 | $1700.00 | $4841.00 |
| Income Before Tax | -$4.15M | -$2.35M | -$2.23M | -$2.78M |
| Income Before Tax Ratio | -$19.61 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $4.00 |
| Net Income | -$4.15M | -$2.35M | -$2.23M | -$2.78M |
| Net Income Ratio | -$19.61 | |||
| EPS | -$7.73 | -$9.54 | -$1.31 | -$1.63 |
| Diluted EPS | -$7.73 | -$9.54 | -$1.31 | -$1.63 |
| Weighted Avg Shares Outstanding | $536908.00 | $246816.00 | $1.71M | $1.71M |
| Weighted Avg Shares Outstanding (Diluted) | $536908.00 | $246816.00 | $1.71M | $1.71M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan